insights_auto
Why is SABS down 3,44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,81 US$
arrow_downward
-3,44%(-0,10) 1D
20 ნოე, 11:17:24 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 US$
High
2,88 US$
Low
2,66 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
121,63 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
2,79 US$
High
2,88 US$
Low
2,66 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
121,63 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
TradingView
·
1 საათის წინ
S&P 500 is on track for the worst week since the April 2025 'Liberation Day' sell-off
ChartMill
·
2 საათის წინ
S&P 500 Premarket Movers Friday: Gainers and Losers
marketscreener.com
·
3 საათის წინ
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
3 საათის წინ
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio